Synchronized Cardioversion for Atrial Fibrillation
Rationale and Clinical Applications
- The American College of Cardiology recommends synchronized cardioversion as the preferred method for electrical cardioversion of atrial fibrillation, as it ensures electrical stimulation does not occur during the vulnerable phase of the cardiac cycle 1, 2
- Synchronized cardioversion involves delivery of an electrical shock synchronized with the intrinsic activity of the heart by sensing the R wave of the ECG, preventing stimulation during the vulnerable phase of the cardiac cycle 1
- Unsynchronized cardioversion (defibrillation) is appropriate only for ventricular fibrillation, where R-wave synchronization is not feasible 1
- Synchronized cardioversion reduces the risk of inducing ventricular fibrillation by avoiding shock delivery during the vulnerable period of ventricular repolarization 3
Indications and Technical Considerations
- The American College of Cardiology indicates that synchronized cardioversion is recommended when rapid ventricular response does not respond promptly to pharmacological measures with ongoing myocardial ischemia, symptomatic hypotension, angina, or heart failure 1
- Current density delivered to the heart depends on defibrillator capacitor voltage, output waveform, electrode size/position, and thoracic impedance 1
- The American College of Cardiology recommends a paddle diameter of 8-12 cm for optimal current delivery 1
- Rectilinear biphasic shocks have shown higher success rates (94%) compared to monophasic shocks (79%) and require less energy 1
Pharmacological Considerations
- The American Heart Association suggests that antiarrhythmic medications may be administered before cardioversion to increase success rates and prevent early recurrence 4
- For patients with AF or atrial flutter of less than 48 hours' duration who are at low thromboembolic risk, anticoagulation should be initiated before or immediately after cardioversion 4
- Anticoagulation should be continued for at least 4 weeks after cardioversion unless contraindicated 4
Special Considerations
- The American Heart Association notes that electrical cardioversion is contraindicated in patients with digitalis toxicity or hypokalemia due to increased risk of ventricular arrhythmias 3
- Patients often have atrial or ventricular premature complexes immediately after cardioversion that may induce further episodes of AF, requiring antiarrhythmic medication to prevent acute reinitiation 5
- For refractory cases, adjusting electrode position, applying pressure over electrodes, or administering antiarrhythmic medication before repeated attempts may improve success rates 4
- In hemodynamically stable patients with pre-excited AF, ibutilide or intravenous procainamide can be beneficial before attempting cardioversion 5
Synchronized Cardioversion in Atrial Fibrillation with Hemodynamic Instability
Introduction to Synchronized Cardioversion
- The American College of Cardiology, American Heart Association, and Heart Rhythm Society recommend synchronized cardioversion as the treatment of choice for hemodynamically unstable atrial fibrillation, with a Class I recommendation (highest level of evidence) for patients who do not respond to pharmacological therapies 6, 7
- In patients with atrial fibrillation and a heart rate of 160/min and a blood pressure of 50/30 mmHg, immediate synchronized cardioversion should be performed, never unsynchronized defibrillation 6, 7
Practical Approach to Synchronized Cardioversion
- No time should be lost on pharmacological therapies in cases of severe hemodynamic instability, such as a blood pressure of 50/30 mmHg 6, 7
- Synchronized cardioversion should be performed without delay in such cases 6, 7
- Atrial fibrillation can often be successfully cardioverted with lower energy levels than atrial flutter 6
- After cardioversion, patients may have atrial or ventricular extrasystoles, which can occasionally trigger further episodes, and may require antiarrhythmic medication to prevent acute reinitiation of tachycardia 6, 7
- Anticoagulation should be initiated according to the same guidelines as for atrial flutter 7
- Beta blockers, diltiazem, or verapamil are useful for frequency control in hemodynamically stable patients, but are absolutely contraindicated in cases with a blood pressure of 50/30 mmHg due to the risk of hypotension 6
R‑Wave Synchronized Direct‑Current Cardioversion for Atrial Fibrillation
Requirement for Synchronization
- Direct‑current cardioversion of atrial fibrillation must always be performed with R‑wave synchronization to avoid inducing ventricular fibrillation; unsynchronized (defibrillation) shocks are only appropriate for ventricular fibrillation. [8][9]
- Synchronization delivers the shock at the peak of the QRS complex, preventing delivery during the vulnerable repolarization (T‑wave) phase. [8][9][10][11]
- Delivery of a shock during the T‑wave can precipitate ventricular fibrillation, a potentially fatal complication. [10][11]
- The term “defibrillation” specifically denotes an unsynchronized discharge and is contraindicated for atrial fibrillation. [8][9]
Technical Implementation
- Choose an ECG lead that clearly shows both the R‑wave amplitude and atrial activity before initiating cardioversion. [9][10]11
- The shock must be timed to the peak of the QRS complex and must never be delivered on the T‑wave. [10][11]
- For low‑energy shocks, aim to synchronize to an R‑wave that follows a prolonged R‑R interval (> 500 ms) to ensure the shock does not fall within the preceding beat’s T‑wave. 10
- Confirm a visible artifact on the monitor that indicates the exact timing of the shock relative to the QRS complex before delivering energy. [10][11]
Energy Settings and Waveforms
- Begin with an initial monophasic energy of 200 J; lower energies (e.g., 100 J) achieve only ~14 % success versus ~95 % with 360 J. [8][12]
Management of Hemodynamically Unstable Patients
- When atrial fibrillation causes hemodynamic instability (e.g., ongoing myocardial ischemia, symptomatic hypotension, angina, or refractory heart‑failure), perform immediate R‑wave‑synchronized cardioversion without delay. 9
- This recommendation is classified as Class I (highest level of evidence) by the ACC/AHA/ESC guidelines. 9